Clinical Trials Browser

Phase 1/2 × Bile Duct Neoplasms × trametinib × Clear all

NCT05874414 2026-05-14

Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma

Phase 1/2 Recruiting

Gastrointestinal

Bile Duct Neoplasms, Cholangiocarcinoma